Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

211.74 +2.30 (+1.10%)
Official Closing Price Updated: 4:10 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Why Is Retail Going Gaga Over INTS Stocks Today?
The firm announced positive data from a study of INT230-6 in the treatment of metastatic and refractory cancers, with 15 of 64 patients in the trial surviving for more than 21 months. 
Via Stocktwits
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options
The company is exploring a range of strategic alternatives that may include, among other options, a sale of assets, Sensei said. 
Via Stocktwits
Topics Workforce
ERNA Stock Rallies On Collaboration With Contract Manufacturer To Advance Lead Cell Therapy Into Clinical Trials
The partnership will focus on activities to advance Ernexa’s lead cell therapy called ERNA-101 for the treatment of ovarian cancer into clinical manufacturing and trials. 
Via Stocktwits
Sagimet Biosciences Stock Soars After Positive Data For Experimental Drug In Acne Study
Via Stocktwits
Intelligent Bio Solutions Stock Rises On New Contract For Drug Testing Technology
The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said. 
Via Stocktwits
Topics Cannabis
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation
Via Stocktwits
Why Did Veritone Stock Fall 17% Today?
Via Stocktwits
Cyngn Stock Eyes Third Day Of Gains: What's Driving The Buzz?
Via Stocktwits
Micro-Cap Emerson Radio Stock Surges By Two-Thirds In 2 Days, And Then Some More, Piquing Retail Traders
Via Stocktwits
GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious
Galecto is focused on developing treatments for oncological and liver diseases. 
Via Stocktwits
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why
The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures. 
Via Stocktwits
Topics Intellectual Property
Why Is Fortress Biotech Stock Falling Today?
Via Stocktwits
Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments
Via Stocktwits
Kala Bio Stock Just Plunged 92% Today – Here’s What Happened
The firm stated that its KPI-012 failed in a mid-stage clinical trial and announced that it intends to preserve cash, including by laying off some of its workforce and deploying other cost-saving... 
Via Stocktwits
Topics Workforce
GUTS Stock Rallied About 28% Today – Here’s Why
Via Stocktwits
bioAffinity Technologies Stock Surged A Whopping 56% Today – Here’s An Important Update
Via Stocktwits
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside
Via Stocktwits
TNF Pharmaceuticals Stock More Than Doubles After Announcing Name Change To Represent Pivot Into Quantum-Class Computing
Via Stocktwits
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug
In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis. 
Via Stocktwits
Why Did NanoVibronix Stock Jump A Whopping 74% Today?
Via Stocktwits
Helius Medical Stock Rockets 169% After Company Raises $500M To Make Solana Its Primary Treasury Asset: Retail Cheers The Deal
Via Stocktwits
Robinhood Draws Wall Street Praise Over Launch Of New Social Media Platform At HOOD Summit – More Details Inside
Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. 
Via Stocktwits
Topics Artificial Intelligence Economy
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
Via Stocktwits
Professional Diversity Network Stock Exploded Over 400% Today – Here’s An Update
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
Via Stocktwits
Soho House Nears $9-Share Go-Private Deal: Report
Via Stocktwits
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued
Via Stocktwits
American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree
Via Stocktwits
Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation
The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said. 
Via Stocktwits
Topics Electric Vehicles
Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening
Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.